Pfizer, Inc.

PFE

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 12:26:10 2024-12-03 pm EST			5-day change	1st Jan Change
25.74 ^USD	-0.33%		-0.00%	-10.49%

Nov. 29	Berenberg Adjusts Price Target on Pfizer to $29 From $27, Maintains Hold Rating	MT
Nov. 29	Analyst recommendations: Apple, Dell, Pfizer, Wall Disney, GSK...

PFIZER INC : UBS remains Neutral

October 18, 2023 at 07:53 am EDT

In his latest research note, analyst Colin Bristow confirms his recommendation. The broker UBS is keeping its Neutral rating. The target price remains set at USD 36.

Latest news about Pfizer, Inc.

Berenberg Adjusts Price Target on Pfizer to $29 From $27, Maintains Hold Rating	Nov. 29	MT
Analyst recommendations: Apple, Dell, Pfizer, Wall Disney, GSK...	Nov. 29
Health Care Up Amid Cyclical Bias -- Health Care Roundup	Nov. 25	DJ
GC Biopharma USA Names Sean Zam as Head of Sales and Marketing	Nov. 22	CI
Sector Update: Health Care Stocks Rise Pre-Bell Thursday	Nov. 21	MT
Zai Lab, Pfizer Collaborate for Marketing Antibacterial Drug in China	Nov. 21	MT
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug Xacduro® (Sulbactam-Durlobactam)	Nov. 21	CI
UK Tribunal Fines Pfizer, Flynn GBP69 Million For Excessive Pricing of Epilepsy Medicine	Nov. 20	MT
Health Care Climbs as Obesity-Drug Makers Rebound - Health Care Roundup	Nov. 20	DJ
US CDC expects COVID and RSV levels to increase in coming weeks	Nov. 20	RE
Pfizer, Flynn Get Fined $87.3 Million by UK Tribunal for Excessive Pricing on Epilepsy Drug	Nov. 20	MT
UK Tribunal Fines Pfizer, Flynn $87.3 Million for Excessive Pricing	Nov. 20	MT
European Equities Close Lower in Wednesday Trading; ECB Sees Elevated Financial Stability Risk	Nov. 20	MT
Top Midday Stories: Comcast to Spin Off Cable TV Networks; Target Tumbles on Q3 Earnings Miss, Lowered Full-Year Guidance	Nov. 20	MT
Global markets live: Pfizer, Alphabet, Comcast, Ford, Nokia...	Nov. 20
Nvidia's market might	Nov. 20
Pfizer's Hympavzi Gets EU Marketing Authorization for Severe Hemophilia A, B	Nov. 20	MT
Pfizer: Marketing authorization for Hympavzi in the EU	Nov. 20	CF
Pfizer: new Chief Scientific Officer on January 1	Nov. 20	CF
Pfizer Names Chris Boshoff as Chief Scientific Officer, R&D Head	Nov. 20	MT
Pfizer Names Chris Boshoff Chief Scientific Officer, President of Research & Development, Effective Jan. 1	Nov. 20	MT

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (52.3%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (25.6%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (19.9%); - other (2.2%). Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (33.8%).

Employees

88,000

Sector

Pharmaceuticals

Calendar

2025-02-03 - Q4 2024 Earnings Release (Projected)

More about the company